Cancer remains a leading cause of death globally, with lung cancer being particularly lethal. Despite advancements in diagnostics and therapies, the five-year survival rates for advanced tumors have ...

A recent study published in Engineering has shed new light on the mechanisms underlying the metastasis of head and neck squamous cell carcinoma (HNSCC). The research identified enolase 2 (ENO2), a ...

Combined, these findings show that CMA displays a broad targetability on multiple steps of the EMT process and indicate a substantial role of CMA in regulating the stability of pro-metastatic and ...

With the use of T cell receptor T cells (TCR-T cells) and chimeric antigen receptor T cells (CAR-T cells), T-cell immunotherapy for cancer has advanced significantly in recent years. CAR-T cell ...

About 18 years ago, a 4-year-old girl with a rare nerve cell cancer received an infusion of immune cells that were genetically engineered to fight the disease. Since then, she has remained cancer ...

HER2-Selective Tyrosine Kinase Inhibitor, Zongertinib (BI 1810631), in Patients With Advanced/Metastatic Solid Tumors With HER2 Alterations: A Phase Ia Dose-Escalation Study The article by Mascarenhas ...

Tumor marker blood tests may help inform various aspects of cancer care, including diagnosis, staging, treatment planning, and outlook. However, they’re often not the only diagnostic tests used.

HER2-Selective Tyrosine Kinase Inhibitor, Zongertinib (BI 1810631), in Patients With Advanced/Metastatic Solid Tumors With HER2 Alterations: A Phase Ia Dose-Escalation Study ...

Cell therapies are a fundamental aspect of regenerative medicine. Credit: Anusorn Nakdee via Shutterstock. Regenerative medicine, a rapidly advancing field, can be generally defined as a therapeutic ...

Ovarian cancer actually refers to several different types of cancer-- more than 30, in fact. The types of ovarian cancer are grouped by the kind of cell where they start. Your ovaries have three ...